Oppenheimer Reiterates Outperform Rating on CRISPR Therapeutics (CRSP)
Go back to Oppenheimer Reiterates Outperform Rating on CRISPR Therapeutics (CRSP)| (NASDAQ: CRSP) | Delayed: 59.20 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.20 | 52 Week High | $18.88 | |||
| Open | $59.20 | 52 Week Low | $13.75 | |||
| Day High | $59.20 | P/E | N/A | |||
| Day Low | $59.20 | EPS | $0.00 | |||
| Volume | 2,678 | |||||
